Absci Corporation EBT margin

EBT margin of ABSI for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT margin growth rates and interactive chart. The Earnings before tax margin. Calculated as earnings before tax divided by revenue. Measures the profitability of a company after all expenses are paid but before taxes. This is useful to compare various companies in an industry that might have different tax regimes or tax rates.

Highlights and Quick Summary

  • EBT margin for the quarter ending September 30, 2023 was -2951.61% (a 138.55% increase compared to previous quarter)
  • Year-over-year quarterly EBT margin increased by 130.12%
  • Annual EBT margin for 2022 was -1833.39% (a -20.2% decrease from previous year)
  • Annual EBT margin for 2021 was -2297.34% (a 665.09% increase from previous year)
  • Annual EBT margin for 2020 was -300.27% (a -6.05% decrease from previous year)
  • Twelve month EBT margin ending September 30, 2023 was -1541.59% (a 17.27% increase compared to previous quarter)
  • Twelve month trailing EBT margin decreased by -15.92% year-over-year
Trailing EBT margin for the last four month:
30 Sep '23 30 Jun '23 31 Mar '23 31 Dec '22
-1541.59% -1314.54% -1611.1% -1833.39%
Visit stockrow.com/ABSI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT margin of Absci Corporation

Most recent EBT marginof ABSI including historical data for past 10 years.

Interactive Chart of EBT margin of Absci Corporation

Absci Corporation EBT margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 -2951.61% -1237.33% -1839.87% – –
2022 -1282.66% -1163.82% -2889.22% -3525.4% -1833.39%
2021 -1809.09% -1646.33% -6430.63% -1076.11% -2297.34%
2020 -181.05% -409.17% -533.33% -464.69% -300.27%
2019 – – – – -319.61%

Business Profile of Absci Corporation

Sector: Healthcare
Industry: Biotechnology
© stockrow.com